Next up: Vermont views on wheels! Hannah and Magnolia are all geared up for their biking adventures. The Tesler and Waterman families team up with Vermont Adaptive Ski & Sports to create an adaptive biking experience that matches the girls’ speed. The bikes are adapted to meet each rider’s needs - foot-secure pedals or a flat platform where their feet can rest comfortably. Strapped in and ready to ride, nothing can stop Hannah and Magnolia from chasing the scenic Green Mountains️. Watch the new episode: https://bit.ly/45CoAiv. #RettSyndrome #RettRevealed
Acadia Pharmaceuticals Inc.
Pharmaceutical Manufacturing
San Diego, California 98,540 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
About us
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For over 30 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of Prader-Willi syndrome, Alzheimer’s disease psychosis and multiple other programs targeting neuro-psychiatric and neuro-rare diseases. See our community guidelines: http://bit.ly/4lFiRxK
- Website
-
http://Acadia.com
External link for Acadia Pharmaceuticals Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 1993
Locations
-
Primary
12830 El Camino Real
Suite 400
San Diego, California 92130-3331, US
-
502 Carnegie Center
Suite 300
Princeton, New Jersey 08540, US
Employees at Acadia Pharmaceuticals Inc.
-
John Schmidt
Executive Neuroscience Sales/Rare Disease at ACADIA Pharmaceuticals Inc.
-
Colin O'Carroll, PhD MBA
Drug discovery & development
-
John Van Johnston
-
Jammee Post
Commercial & Field Operations & Planning Professional ◆ Analytics & Reporting ◆ Sales Force Size & Structure ◆ CRM ◆ Targeting ◆ Data Governance ◆…
Updates
-
We’re looking forward to participating in several #investor conferences next month, including the Morgan Stanley 23rd Annual Global Healthcare Conference, H.C. Wainwright & Co., LLC 27th Annual Global Investment Conference, and Cowen Inc.'s 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit. Learn more: https://bit.ly/3JzjvyP.
-
-
Women have always been at the forefront of groundbreaking advancements in healthcare and science, including in the field of neuroscience. Despite this, women occupy only 25% of executive roles – highlighting a persistent leadership gap. At Acadia, advancing women in leadership is core to who we are and how we operate. In honor of #WomensEqualityDay, read more about CEO Catherine Owen Adams' perspective on the importance of championing women to advance science and the business imperative of women in leadership: https://bit.ly/4n0bcus.
-
-
Today, we announced the appointment of Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer. In this role, Konstantina will lead our business development and corporate strategy efforts and will serve as a member of the Company’s Executive Leadership Team. Learn more: http://bit.ly/4oUhu0j
-
-
Exciting week ahead for the #RettSyndrome community! We’re looking forward to joining the Rett Syndrome Research Trust at Reverse Rett Colorado and Reverse Rett San Francisco this week. Learn more and register here: https://bit.ly/4egEEHY.
-
-
Hallucinations and/or delusions may happen at any stage of #ParkinsonsDisease, but some factors increase the risk. Learn what they are and why early conversations with a doctor matter: https://bit.ly/2K8jwIX. #MoretoParkinsons
-
Today, we shared our Q2 2025 #earnings results. Read our $ACAD financial summary and key updates here: http://bit.ly/457gONt.
-
-
We are excited to announce that Scott Cenci has joined Acadia as our new Senior Vice President, Chief Information and Data Officer. In this newly created role, Scott will lead Acadia’s digital transformation, including technology, data, and AI strategy, and will serve on the Executive Leadership Team. Learn more: http://bit.ly/4lfdrsq
-
-
New adventure. New crew! Magnolia and the O’Shea family set sail in Connecticut, ready to explore the sea. With help from the New England Science & Sailing Foundation, Georgina and Magnolia board an adaptive sailboat with pivoting bucket seats and 5-point harnesses. These seats provide stability and support—helping people with complex medical needs experience the freedom of open water. Watch as the girls take turns at the helm, showing off their captain skills and earning their sea names: Captain Georgina and Captain Magnolia: https://bit.ly/46CoyIn.
-
Happy #NationalInternDay from Acadia! We are so grateful to have our second intern cohort of incredible bright minds this summer. For the second year, we continue to partner with Project Onramp, selecting ten motivated interns to work across several departments in our San Diego office. Along with getting real-world work experience, our interns have been participating in enrichment opportunities and culture events. We are so excited for them to continue bringing fresh perspectives and ideas to Acadia!
-